Stock Evaluator: Sotera Health Company (SHC)

Sotera Health Company SHC

$15.91 -0.30 -1.85%
November 20, 2026 4:00:00 PM EST November 10, 2021 Volume: 1,730,990
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Life Sciences Tools & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Commentary & Analysis


Financial Summary

Share Statistics SHC Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $4,544.4 $3,333.2 68%
Shares Out (Mil) 289.2 107.2 82%
Institutional Ownership 97.1% 88.4% 72%
Float (Mil) 202.1 79.2 73%
Beta 1.93 1.15 91%
Avg Daily Volume (000s) 2,464 958 84%
Price Change
(52-week)
0.8% 81.2% 55%
Growth SHC Industry
Median
Percentile
(All Stocks)
Sales (5yr) 7.3% 7.5% 48%
Net Income (5yr) 32.1% (12.9%) 86%
EPS (5yr) 29.7% 1.4% 81
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) 7.1% (15.0%) 68%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 10 10 10
Current EPS $0.260 $0.983 $1.065
Month Ago EPS $0.276 $0.984 $1.075
# Rev Up 1 1 4
# Rev Down 1 0 1
Three Months Ago EPS $0.276 $0.985 $1.075
Year/Year Chg 30.0% 264.1% 332.2%
Financials SHC Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $1,230 $816 52%
Net Income (TTM) (Mil) $174 ($24) 65%
EPS (TTM) $0.608 ($0.300) 54%
Operating Cash Flow (TTM) (Mil) $332 $79 65%
Net Cash Flow (TTM) (Mil) $111 $4 78%
Long-Term Debt (Q1) (Mil) $2,253 $263 76%
Enterprise Value (Q1) (Mil) $6,608 $3,667 67%
Valuation SHC Industry
Median
Percentile
(All Stocks)
P/B 6.19 2.97 87%
P/E 26.5 33.8 70%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) 0.9 6.4 46%
Ratios SHC Industry
Median
Percentile
(All Stocks)
Gross Margin 54.6% 47.5% 67%
Net Margin 14.1% (3.5%) 71%
ROA 5.3% (4.5%) 72%
ROE 27.0% (3.6%) 85%
Liabilities to Assets 78.4% 40.9% 74%
F-Score 7 5 82%

Sotera Health Company did not pass any screens on 11/20/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors